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ABSTRACT
Background/aims To determine the reproducibility
among readers of two independent certiﬁed centres, the
Vienna Reading Center (VRC) and the University of
Wisconsin-Madison Reading Center (UW-FPRC) for
optical coherence tomography (OCT) images in age-
related macular degeneration (AMD).
Methods Fast macular thickness scans and 6 mm cross
hair scans were obtained from 100 eyes with all
subtypes of AMD using Stratus OCT. Consensus readings
were performed by two certiﬁed OCT readers of each
reading center using their grading protocol. Common
variables of both grading protocols, such as presence of
cystoid spaces, subretinal ﬂuid, vitreomacular traction
and retinal pigment epithelial detachment, were
compared using k statistics. In addition, the intraclass
correlation coefﬁcient (ICC) was calculated for centre
point thickness (CPT) of values re-measured manually in
the presence of alignment errors.
Results The reproducibility was dependent on the
variable measured with a k value of 0.81 for the
presence of cystoid spaces, 0.78 for the presence of
subretinal ﬂuid and 0.795 for the presence of
vitreomacular traction. The lowest reproducibility was
found for the presence of retinal pigment epithelial
detachment with a k value of 0.51. The CPT was re-
measured in 29 out of 100 scans at both sites with an
ICC of the re-measured thicknesses of 0.92.
Conclusion OCT scan data are crucial in monitoring
treatment efﬁcacy in AMD clinical trials. For comparison
of results obtained by different reading centers, the inter-
reading center reproducibility is essential. Although the
reproducibility is generally high, the reliability depends on
the selected morphological parameters.
INTRODUCTION
Optical coherence tomography (OCT) is a rapid,
non-invasive imaging method capable of generating
high-resolution optical cross-sections of the
macula. A number of studies have elucidated the
usefulness of OCT in the evaluation and follow-up
of retinal conditions such as age-related macular
degeneration (AMD).
1 2
OCT has also become a critical tool for assessing
the morphological response of the retina to thera-
peutic interventions. OCT-derived measurements
of the central retinal thickness are important
outcome measures in clinical trials for treatment of
macular oedema
3e5 and choroidal neovascularisa-
tion.
67In addition to quantitative metrics, OCT is
widely used for qualitative assessment to establish
the presence of cystoid spaces, pigment epithelium
detachments (PEDs), subretinal ﬂuid (SRF) or
vitreomacular pathologies such as vitreomacular
traction (VMT). Recently, some of these variables
have been used to determine the need for initial
treatment and subsequent re-treatment in clinical
trials evaluating novel treatment modalities in the
management of neovascular AMD.
8 In current
clinical trials of neovascular AMD, the most
commonly used OCT system is the Stratus OCT
(Carl Zeiss Meditec, Dublin, California, USA) with
the fast macular thickness map (FMTM) scan
mode. However, the automated algorithms
frequently misidentify the inner and outer retinal
boundaries. This leads to an inaccurate thickness
measurement requiring a manual re-measurement.
For the evaluation of the various morphological
characteristics of exudative AMD, typically the
cross hair line scans have been obtained.
In multicentre AMD clinical trials, OCTscans are
being sent to a central reading center (RC) for
evaluation of morphology and accuracy of auto-
mated thickness measurements. Certiﬁed readers
interpret retinal morphology according to stand-
ardised protocols and the centre point thickness
(CPT) is re-measured manually when the auto-
mated measurement is incorrect. Controlled RC
procedures provide the most reliable method to
obtain realistic and solid OCT data and to conclude
on the value and beneﬁt of OCT imaging in intra-
vitreal treatment of AMD. Therefore, certiﬁed RCs
play an important role for deﬁning OCTstrategies.
Although data have been published regarding
reproducibility within OCT RCs,
9 little informa-
tion is available regarding reproducibility between
RCs. However, Food and Drug Administration
(FDA) approved trials are usually performed as two
independent trials in US and non-US sites with
individual RCs responsible for each trial. Also,
a comparison of strategies and results from
different centres allows a solid evaluation of reli-
ability and reproducibility.
However, the comparability and reproducibility
of OCT gradings of readers from independent RCs
using different grading protocols have not been
evaluated to our knowledge. Herein, we determine
the inter-reading centre reproducibility for OCT
image evaluation between an established European
and an established US Reading centre, the Vienna
Reading Center (VRC) and the Reading Center of
the University of Wisconsin-Madison (UW-FPRC),
respectively.
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Clinical scienceMETHODS
Data collection
In this retrospective study, cases were collected sequentially
from a list of patients with the clinical diagnosis of AMD who
underwent Stratus-OCT imaging of the macula at the retina
unit of the Department of Ophthalmology of the Medical
University of Vienna. Approval for the analysis of OCT images
was obtained from the Institutional Review Board of the
Medical University of Vienna and of the University of
Wisconsin-Madison. The research adhered to the tenets set forth
in the Declaration of Helsinki.
All scans were acquired by certiﬁed OCToperators following
pupil dilatation using the FMTM scan mode for quantitative
measures of the CPT and the 6 mm cross hair scan mode for
qualitative assessment of retinal morphology.
The FMTM protocol acquires six 6 mm radial lines consisting
of 128 A-scans per line in 1.92 s of scanning, whereas the cross
hair protocol includes two 6 mm lines (6e12 to 9e3o ’clock) at
512 scan resolution.
Scans were analysed with the version 4.0 software (Carl Zeiss
Meditec), all patient identifying data were removed and
a consecutive patient number was given. Data for each case were
sent as printouts to the UW-FPRC and as digital data ﬁles to the
VRC. After completion of the grading procedure, the data ﬁles
with the results were independently sent by the two RCs to the
Department of Medical Statistics of the Medical University of
Vienna for data analysis keeping each of the RCs blinded from
the results of the other RC.
Grading procedure
The OCT image sets were examined as printouts at the UW-
FPRC. Standard grid templates for identiﬁcation of the centre
point and the central mm, printed on a transparent stock, were
overlaid on the scans and used for grading of location and extent
of the variables.
A validated computer assisted grading software was used at
the VRC. This software imports OCT scan data exported form
the Stratus-OCTand allows the grader to electronically measure
various parameters in the 6 mm cross hair and FMTM scans.
The distances are calculated in pixels and using the dimensions
of the B scan image, the pixels are converted into micrometers. A
superimposed grid indicating the centre point and the central
mm was used for grading of location and extent of parameters.
A consensus reading was performed by two certiﬁed readers at
each RC. The readers were trained according to the individual
protocol of the related RC and certiﬁcation was awarded on the
successful completion of all requirements. All readers are actively
participating in the grading of Stratus OCT scans of clinical
trials evaluating treatments for AMD.
The 6 mm cross hair scans were graded for presence and
location of cysts, subretinal ﬂuid (SRF), pigment epithelial
detachment (PED) and vitreomacular traction (VMT). FMTM
scans were graded for presence of alignment errors at the centre
point. Scans with alignment errors of more than 25% of the
retinal thickness at the centre point in at least one of the six
FMTM scans and with a standard deviation of CPT at >10%
were manually re-measured using a calibrated ruler at the UW-
FPRC and digitally at the VRC.
Deﬁnition of morphological parameters
Before the start of the study, staff from the two RCs discussed
the grading parameters but did not thereafter interact. Cysts
were deﬁned as round, minimally reﬂective spaces within the
neurosensory retina. SRF was identiﬁed as a non-reﬂective space
between the posterior boundary of the neurosensory retina and
the retinal pigment epithelium/choriocapillaris reﬂection.
Localisation of cysts and SRF was categorised : (1) being outside
the central mm and (2) involving the central mm. In addition,
central cysts were categorised as small (<200 mm), medium
(<400 mm) or large (>400 mm).
PED was described as a focal elevation of the reﬂective retinal
pigment epithelium (RPE) band over an optically clear or
moderately reﬂective space. A PED was graded if the elevation
was greater than 400 mm at the base and/or greater than 200 mm
from the surface of the RPE band to the surface of the chorio-
capillaris. Location of PED was described as (1) being outside the
central mm and (2) involving the central mm.
VMT was identiﬁed if a thickened posterior hyaloid was
observed to insert in the foveal/perifoveal area. No grading
regarding extent of VMTwas performed.
Both RCs followed their own grading protocols for the
selected parameters. To compare gradings between the two RCs,
a comparison key was developed.
Statistical methods
Analyses were conducted using the software package SPSS
V.17.0. To quantify the reproducibility of manual re-measure-
ments of the CPT in cases of alignment errors, the intraclass
correlation coefﬁcient (ICC) was calculated. In addition, the
mean, SD, standard error, Pearson p and Bias correction factor
Cb was determined. For CPT re-measurements, absence/pres-
ence, location and extend of cysts, SRF, PED and VMT, the
percentage of agreement and the k statistic were calculated.
k Statistics were interpreted using the ranges suggested by
Landis and Koch
10:0 e0.20, slight agreement; 0.21e0.40, fair;
0.41e0.60, moderate; 0.61e0.80, substantial; and more than
0.80, almost perfect agreement.
RESULTS
The study included 100 eyes of 89 patients with an average age
(SD) of 6768 y (59 female, 41 male). The OCT scans showed
a wide range of morphological changes associated with AMD,
including drusenoid changes, serous, haemorrhagic and ﬁbro-
vascular PED, SRF, intraretinal cysts, VMTor macular oedema.
Manually re-measured CPT
The CPTwas re-measured in 29 out of 100 FMTM scans at both
sites (in 35 scans at the VRC and in 37 scans at the UW-FPRC).
Table 1 shows the reproducibility as to whether or not a re-
measurement was necessary and shows the mean, minimum
and maximum CPT, SD, SE, ICC, Pearson p and Bias correction
factor Cb for the re-measured CPTs at both sites.
Figure 1A shows the Bland-Altman plot of the differences in
the re-measured CPTs (x axis: the average of the CPT values of
the two RCs; y axis: the differences of the CPT measurements
between the two RCs). Figure 1B shows the scatter plot of the
same measurements.
Presence of cysts, SRF, PED and VMT
Results of gradings for presence of cysts, PED, SRF and vitreo-
macular traction are summarised in table 2. Bold values indicate
consistent gradings. The highest reproducibility was found for
presence of cysts with a k value of 0.81 (almost perfect) and the
lowest for PED with a k value of 0.51 (moderate).
The number of detected VMT was low with only two cases
identiﬁed at both sites and one additional at the UW-FPRC.
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Clinical scienceLocation and extend of cysts, PED and SRF
Results of gradings for location and extent of cysts, PED and
SRF are summarised in tables 3 and 4. Table 3 shows the
reproducibility of thickness gradings of cysts at the centre point.
Bold values indicate consistent gradings.
DISCUSSION
The introduction of a novel diagnostic method such as OCTof
the retina into clinical practice, and the acceptance/approval of
used parameters by the responsible institution, requires solid
proof of the value and relevance of the acquired data. In order to
assess treatment efﬁcacy and to evaluate treatment indications,
it is important to gather robust data sets in a controlled manner.
Few prospective clinical trials have included OCT measurements
in a rigorous way using a standardised protocol. Due to the
limited availability of solid data, the technique, although widely
used in clinical routine, has not yet obtained general acceptance
as a gold standard method for monitoring patients with AMD,
by institutions and the community. The data available from
trials such as PRONTO (Prospective Optical Coherence
Tomography Imaging of Patients with Neovascular Age-Related
Macular Degeneration Treated with intraocular Ranibizumab),
11
EXCITE (Efﬁcacy and Safety of Ranibizumab in Patients
With Subfoveal Choroidal Neovascularization Secondary to
Age-Related Macular Degeneration)
12 and SUSTAIN (Study of
Ranibizumab in Patients With Subfoveal Choroidal Neovascu-
larization Secondary to Age-Related Macular Degeneration)
13
are uniformly based on conventional time domain (TD) OCT
using the Stratus-OCT.
Standardised assessment of morphological changes in OCT
scans by one central RC is becoming a widely used method of
determining outcomes in large clinical trials. Beneﬁts of using
a central RC include standardised data acquisition procedures at
the clinical sites, standardised grading procedures by the use of
certiﬁed readers and masking of readers to patient data regarding
treatment assignment. An additional advantage is that the
reproducibility of the readings can be easily assessed.
9
Measurement of retinal thickness and grading for presence,
location and extent of intraretinal cysts, SRF and PED are
currently deﬁned as the primary morphological outcomes in
recent clinical trials evaluating novel treatments for neovascular
AMD.
11 Although these morphological parameters have been
similarly applied by several RCs, there are no studies comparing
OCT gradings between them despite the fact that RCs often
cooperate in clinical trials. RCs developed individual grading
protocols, software tools and measuring devices. There is only
one study comparing results from two fundus photograph RCs
in grading cytomegalovirus retinitis progression.
14 Gradings
were performed on light boxes using standard grid templates and
measuring circles by an ophthalmologist grader at one RC and
by a group of four certiﬁed graders at the other RC. Another
study investigated agreement between clinician and RC gradings
of fundus photographs of diabetic retinopathy.
15 The agreement
between diabetic retinopathy severity classiﬁcation as deter-
mined by ophthalmoscopy performed by retina specialists and
gradings of stereoscopic fundus photographs at a RC was
determined. However, to our knowledge no study has been
published on the inter-reading centre reproducibility of OCT
gradings.
As more competing trials are being performed worldwide with
increasing numbers of study participants, more RCs are being
involved to satisfy the need for certiﬁed data analysis.
The comparison of consensus readings of different OCT
parametersinAMDshowedahighlevelofagreementbetweenthe
VRC and the UW-FPRC. However, the reproducibility was
dependent on the speciﬁc morphological parameters measured
with a k value of 0.81 for the presence of cystoid spaces, 0.78 for
thepresenceofSRFand0.795forthepresenceofVMT.Thelowest
reproducibilitywasfoundforthepresenceofPEDwithakvalueof
0.51.Reproducibility ofgradings forlocalisation andextentofthe
selected parameters was lower, but still ‘moderate’ with k values
of 0.54 for SRF and 0.51 for PED and ‘substantial’ for intraretinal
cystswithakvalueof0.78.Theseﬁndings,basedonthecapability
Table 1 Scans requiring re-measurements and re-measured values
No of re-measured FMTM scans
VRC
UW-FPRC No Yes Total
No 57 66 3
Yes 8 29 37
Total number 65 35 100
k 0.70
SE 0.07
95% CI 0.55 to 0.84
Manually re-measured centre point thickness
No of re-measured scans at both sites 29
Intraclass correlation coefﬁcient 0.92
95% CI 0.845 to 0.96
Pearson p (precision) 0.94
Bias correction factor Cb (accuracy) 0.9824
VRC UW-FPRC
Mean (mm) 298 276
SE 21.3 22.5
SD 114.9 121.2
Minimum 139 115
Maximum 501 544
Values in bold indicate consistent grading.
FMTM, fast macular thickness map; UW-FPRC, University of Wisconsin-Madison Reading
Center; VRC, Vienna Reading Center.
Figure 1 (A) Blant-Altman plot
comparing mean and difference of
manually re-measured centre point
thickness (CPT) values between the two
reading centres. (B.) Scatterplot of
manually re-measured CPT values from
the two reading centres. UW-FPRC,
University of Wisconsin-Madison
Reading center; VRC, Vienna Reading
Center.
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difﬁculties in identifying speciﬁc morphologic pathologies in
generaldfor example, lesions of the RPE clearly represent a chal-
lenge for diagnosis and grading, while the identiﬁcation of intra-
retinal cysts appears to be more reliable. These observations from
a certiﬁed centre condition allow an estimation of the value of
such data from studies not using certiﬁed procedures.
These data appear even more relevant as a digital grading
method at the VRC was compared to a paper print grading
method at the UW-FPRC. In general, all reading parameters were
discussed by members of the two RCs and deﬁned prior to the
study but there was no interaction between the two RCs
thereafter offering completely independent analysis. Limitations
of this analysis include the restricted range of morphological
parameters included and the relatively small number of study
cases. In addition, this study is based solely on Stratus OCT
data, which is still the most commonly used OCT in research
protocols to date; however, it will be probably replaced soon by
Fourier domain OCT (FD-OCT) devices. Stratus OCT imaging
is based on six radial, cross-sectional scans and the information,
therefore, is limited to a few randomly selected locations and an
overall low resolution of structural details. The FD-OCT uses
a fast spectral-domain technique and performs scans in a raster
pattern throughout the entire macular area at a superior reso-
lution of 5 mm in axial and 20 mm in transverse directions. As
a result, the retinal morphological features such as RPE or
vitreomacular interface abnormalities can be imaged at all
locations and in more details.
In AMD, there may be up to a 92% rate of inner or outer
retinal boundary errors with subsequent incorrect segmentation
for retinal thickness.
16 Recently, studies have shown the supe-
riority of the central subﬁeld for analysis of the central retinal
thickness when compared to the centre point thickness
because of reduced variability.
17 Although the majority of the
FD-OCT platforms will allow recalculation of central subﬁeld
thickness measurements, only the centre point thickness can be
re-measured manually on Stratus OCT when the automated
algorithm fails. The CPT measurements in case of alignment
errors were highly reproducible between the two RCs with
a k value of 0.70 and an ICC of 0.92. However the mean CPT
re-measured by readers of the VRC was 22 mm higher than the
mean of the re-measured CPTat the UW-FPRC. The agreement
on thickness gradings of central cysts was ‘substantial’ with
a k value of 0.75. This high degree of measurement agreement is
Table 2 Presence of cystoid spaces, SRF, PED and vitreomacular
traction
VRC
Cystoid spaces SRF
UW-FPRC No Yes Total No Yes Total
No 65 87 3 52 86 0
Yes 0 27 27 3 37 40
Total no 65 35 100 55 45 100
k 0.81 0.78
SE 0.06 0.06
95% CI 0.69 to 0.94 0.65 to 0.90
VRC
PED Vitreomacular traction
UW-FPRC No Yes Total No Yes Total
No 32 26 58 97 09 7
Yes 0 42 42 1 2 3
Total no 32 68 100 98 2 100
k 0.51 0.795
SE 0.07 0.20
95% CI 0.37 to 0.65 0.40 to 1.0
Values in bold indicate consistent gradings.
FMTM, fast macular thickness map; PED, pigment epithelium detachments; SRF, subretinal
ﬂuid; UW-FPRC, University of Wisconsin-Madison Reading Center; VRC, Vienna Reading
Center.
Table 3 Location, extent and thickness at the centre point of cystoid
spaces
Location and extent
VRC
UW-FPRC 0 1 2 Total
0 65 0 0 73%
12 3 05 %
26 2 22 30%
Total 73% 5% 12% 100%
0dAbsent k 0.78
1dDeﬁnite, outside central 1 mm SE 0.07
2dDeﬁnite, central 1 mm involved 95% CI 0.53 to 0.82
Thickness at the centre point
VRC
UW-FPRC 0 1 2 3 Total
0 83 2 1 0 86%
10 7 3 0 10%
20 0 2 13 %
30 0 0 1 1%
Total 83% 9% 6% 2% 100%
0dNot applicable k 0.75
1dSmall, <200 mm SE 0.09
2dMedium, <400 mm 95% CI 0.56 to 0.93
3dLarge, >400 mm
Values in bold indicate consistent gradings. UW-FPRC, University of Wisconsin-Madison
Reading Center; VRC, Vienna Reading Center.
Table 4 Location and extent of subretinal ﬂuid and pigment epithelial
detachment
Subretinal ﬂuid
VRC
UW-FPRC 0 1 2 3 Total
0 52 5 7 1 65%
12 6 2 0 10%
25 3 17 0 25%
3 1000 0%
Total 59% 14% 26% 1% 100%
0dAbsent k 0.54
1dDeﬁnite, outside central 1 mm SE 0.08
2dDeﬁnite, central 1 mm involved 95% CI 0.37 to 0.69
3dCannot grade
Pigment epithelial detachment
VRC
UW-FPRC 0 1 2 3 Total
0 32 2 23 0 57%
10 4 20 6 %
20 1 35 0 36%
30 0 1 0 1%
Total 32% 7% 61% 0% 100%
0dAbsent k 0.51
1dDeﬁnite, outside central mm SE 0.08
2dDeﬁnite, central mm involved 95% CI 0.36 to 0.66
3dCannot grade
Values in bold indicate consistent gradings.
UW-FPRC, University of Wisconsin-Madison Reading Center; VRC, Vienna Reading Center.
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Clinical sciencerelevant for clinical trials in which lesion thickness is a primary
or secondary study endpoint.
A constant high level of agreement between RCs probably
requires the development of a quality control programme and
RCs may need to consider establishing and maintaining coop-
erative programs to harmonise their measuring and grading
procedures and settings. Otherwise, a comparison of results
from trials analysed by different RCs cannot be certain of the
impact of possible differences between RCs. However, optimal
standardisation and reliability is essential to identify the value of
new surrogate parameters in the development of novel treat-
ment strategies, which also introduce appropriate strategies for
patient management and follow-up.
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